Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
19,834
-
Shares change
-
+6,571
-
Total reported value, excl. options
-
$2,694,436
-
Value change
-
+$892,633
-
Number of buys
-
3
-
Number of sells
-
2
-
Price
-
$135.85
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2023
As of 31 Dec 2023 ISHARES TR - ISHARES BIOTECH (IBB) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,834 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, MORGAN STANLEY, CITIGROUP INC, GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, BNP PARIBAS FINANCIAL MARKETS, UBS Group AG, ROYAL BANK OF CANADA, COMMERCE BANK, and WELLS FARGO & COMPANY/MN.
This table shows 868 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.